Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions

<div>Effect of Itolizumab treatment on PASI score of patients.</div>

Dermatology Research and Practice

Figure 1: Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions 